DisantoGPakpoorJMorahanJM. Epstein-Barr virus, latitude and multiple sclerosis. Mult Scler2013; 19: 362–365.
2.
AscherioAMungerKL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol2007; 61: 288–299.
3.
HandelAEWilliamsonAJDisantoG. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PloS One2010; 5(9)
4.
NielsenTRRostgaardKNielsenNM. Multiple sclerosis after infectious mononucleosis. Arch Neurol2007; 64: 72–75.
5.
PakpoorJDisantoGGerberJE. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: A meta-analysis. Mult Scler2013; 19: 162–166.
6.
LevinLIMungerKLO’ReillyEJ. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol2010; 67: 824-830.
7.
LevinLIMungerKLRubertoneMV. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA2005; 293: 2496–2500.
